Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Isotechnika Pharma Inc
IPHAF
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPHAF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Next
(0)
•••
go4future
X
View Profile
View Bullboard History
Post by
go4future
on Jan 23, 2010 10:26pm
Next Gen Voclosporin...
knowledge is spreading across the globe. India in this case, appears it could be a potentially large Uveitis target market for Lux. According to this 2010 published article, India has more than 3.5
...more
(5)
•••
Biostocks01
X
View Profile
View Bullboard History
Comment by
Biostocks01
on Jan 22, 2010 5:50pm
RE: still following the money
Good post!!
(0)
•••
hopskipjump
X
View Profile
View Bullboard History
Post by
hopskipjump
on Jan 22, 2010 3:28pm
still following the money
https://www.crainsnewyork.com/article/20100122/SMALLBIZ/100129952#good tradin'-ot
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 22, 2010 3:17pm
Impertinent view
Back in the "70's" as was the custom, I indulged in wheat-based beverages and chemical stimulants.Usually ended up in a state , much like the good
...more
(0)
•••
WASKERWISK
X
View Profile
View Bullboard History
Comment by
WASKERWISK
on Jan 21, 2010 4:53pm
RE: Lux Royalty Estimates
Regarding the percentage royalties, ISA (and BioMS) was getting double that in previous deal and the Lux deal was made in the rosy times. I am betting closer to 20%.Regarding multiples
...more
(0)
•••
go4future
X
View Profile
View Bullboard History
Comment by
go4future
on Jan 21, 2010 4:37pm
RE: Pertinent news for Voclosporine Lux-ISA
Restasis is also a big factor associated with partnership of Inspire and Allergan. Arcticle is a year old but provides some revenue figures associated with Restasis for both Inspire and Allergan
...more
(0)
•••
professional11
X
View Profile
View Bullboard History
Post by
professional11
on Jan 21, 2010 3:49pm
Lux Royalty Estimates
Royalty Estimates: Medius in 2001 determined that average royalties for pharmaceuticals in the pre-clinical stage ranged from 0-5%, while royalties in Phase I were 5-10% and royalties for launched
...more
(0)
•••
professional11
X
View Profile
View Bullboard History
Post by
professional11
on Jan 21, 2010 3:39pm
Pertinent news for Voclosporine Lux-ISA
Inspire's Prolacria Fails in Phase III Dry Eye StudyShares of Inspire Pharmaceuticals Inc. were down 12 % at noon trading on news that its Phase III study of Prolacria in dry eye disease missed
...more
(0)
•••
throughmud
X
View Profile
View Bullboard History
Comment by
throughmud
on Jan 21, 2010 3:27pm
RE: RE: Something's Brewing
This would be a great time for a good news release from, say, Lux that directly impacts ISA. It will take some deal of good news to move ISA's SP out of its state of ennui.mud
(0)
•••
biodelatech
X
View Profile
View Bullboard History
Comment by
biodelatech
on Jan 21, 2010 1:27pm
RE: Re: Kool-Aid Brewing
I would deignore you, if I had been ignoring you.
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 21, 2010 1:23pm
Re: phoenix rising
TEEVEE should be re-appearing soon!
(7)
•••
rickkulesza
X
View Profile
View Bullboard History
Comment by
rickkulesza
on Jan 21, 2010 1:17pm
RE: Re: Kool-Aid Brewing
hey, thans for ]relieving me at 20 centsther's more at .195 - go get em !!!
(48)
•••
ISAloser247
X
View Profile
View Bullboard History
Post by
ISAloser247
on Jan 21, 2010 12:48pm
Re: Kool-Aid Brewing
" Everything is possible in love and dreams", maybe Novartis, who bought Alcon, who was to buy Lux, is involved?
...more
(0)
•••
throughmud
X
View Profile
View Bullboard History
Comment by
throughmud
on Jan 21, 2010 12:24pm
RE: Something's Brewing
Maybe it's something to do with the late-stage failure of Inspire Pharmaceuticals' Prolacria. Prolacria was inPhase III for treatment of dry eye disease. mud
(2)
•••
labumba
X
View Profile
View Bullboard History
Comment by
labumba
on Jan 21, 2010 12:02pm
RE: RE: RE: Something's Brewing
should be " hotstocked.com "
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income